J. Goldman & Co’s Biohaven BHVN Stock Holding History

J. Goldman & Co’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,543	Closed	-$686K	–	452
2024 Q1	$686K	Buy	+12,543	New	+$621K	0.02%	301

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

J. Goldman & Co's BHVN Position: Q2 2024 in Review

J. Goldman & Co sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 12,543 shares — an estimated $686K sold.

J. Goldman & Co first reported a position in BHVN in Q1 2024 and held it in 1 quarter. The position peaked at $686K in Q1 2024. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

J. Goldman & Co reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
J. Goldman & Co sold 12,543 Biohaven shares in Q2 2024, an estimated $686K.
J. Goldman & Co first reported a position in Biohaven in Q1 2024 and held it in 1 quarter.
J. Goldman & Co's Biohaven position peaked at $686K in Q1 2024.
225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.